IN DATA WE TRUST
Funso Kumolu
INDUSTRY TRENDS
Christy Bryant
INNOVATION OVERDRIVE
Scott Pearson
WORKPLACE MIXTAPE
Eddy Sookswat
50

Tells us who owns the data and who’s permitted to use it.

DATA RIGHTS

CSI tracks and manages the data rights of our 600+ TERABYTES of data to ensure we are accessing the right data from the right clients for the right purposes.

50

A credit-based replenishment model eliminates this common 340B inventory problem.

INVENTORY SWELL

McKesson’s VRR and LoopRx products prevent inventory swell by recognizing retail purchases that are already made by the pharmacy.

50

Specialty leakage product launched via MomentimRx.

VELOCITY

A leakage analytics solution designed to help health systems retain scripts.  As the second product launched through MomentimRx, Velocity is estimated to deliver $10M AOP this year.

50

This team’s theme song should be BTO’s “Takin’ Care of [THE] Business”

CSI FINANCE PARTNERS

Innovation results in new products for our customers and for McKesson, requiring us to evolve how we think about, measure and track value.  Our Finance Partners have been key to this innovation evolution.

100

Customer program that has identified $250M+  in savings.

BUYSMARTER

BuySmarter leverages AI-driven insights, and inventory and cost management, to deliver real-time savings to customers.  It's created over $100M in incremental margin for McKesson.

100

On January 1, 2026, 340B up-front discounts will be replaced by this model.

340b REBATE MODEL

Entities will purchase drugs at a higher price (WAC), then receive a manufacturer rebate to bring the final cost down to the 340B ceiling price.

100

Initiative to improve contract transparency and communication loops for VA customers.

DENALI

Once fully implemented, this product will enhance VA contract efficiency and compliance by automating contract changes and product updates.

100

This McKesson business processes >1M prescriptions per day helping patients get the meds they need.

MCKESSON PHARMACY SYSTEMS

Our industry-leading pharmacy management system, EnterpriseRx, helps alleviate manual tasks, manage workload balancing across pharmacies, and simplify daily operations.

150

Data feed responsible for our primary competitive pricing and sourcing intelligence.

PEGASYS

Sourced from EnterpriseRx, Liberty and Macro Helix, this data allows us to predict market events and claw back identified leakage.

150

Federal legislation projected to result in millions of Americans becoming uninsured over the next decade.

ONE BIG BEAUTIFUL BILL (HR1)

Rising costs and reduced reimbursement are making healthcare transformation inevitable, representing an opportunity for us to develop & deliver creative solutions for our customers.

150

Initiative to define the strategy for a unified ordering platform for PSaS

MULAN

By addressing customer pain points caused by fragmented systems, it aims to streamline the digital experience, improve operational efficiency, and strengthen customer engagement.

150

This report outlines the value generated by CSI for the enterprise.

CSI QUARTERLY VALUE REPORT

CSI exists to support all of USPD. We do so by generating and capturing measurable value by enabling solutions to the USPD segments. We report this value quarterly.

200

The average number of searches on Connect each day.

200,000

Search results  are a key driver in converting customers from one equivalent product to another.

200

Consolidation of entities within the pharmaceutical supply chain.

VERTICAL INTEGRATION

Vertical Integration (like 340B contract pharmacies integrated with a PBM) is driving questions about pricing transparency, a trend we’ll continue to watch.

200

A digitally-native approach to product development.

TECHNICAL PRODUCT MANAGEMENT

Our organizational shift to a more technical product approach will accelerate responsiveness, moving us from delivering in weeks and months, vs quarters and years.

200
McKesson spun off this distribution division in the late 1980s.  

WINE & SPIRITS

It is critical for us to continue to stay focused on the topics and the work where we have the right to play, and to make a difference in the lives of others.

250

The average time a Connect order is placed after the initial search.

2 DAYS

Getting teams connected to this information  is an early signal for demand.  We leverage this data to improve the resilience of our supply chain.

250

The highest increase in 15 years to health benefit costs  is attributed (in part) to this group of drugs.

GLP-1s

Pharmacy costs account for ~25% of healthcare spending.  GLP-1 drugs are a significant recent driver of this, with a total of 10 FDA-approved drugs covering 8 different indications.

250

McKesson’s TPA-agnostic virtual credit-based replenishment solution.

LOOPRX

McKesson’s TPA-agnostic virtual credit-based replenishment solution for 340B customers, the first generally available product commercialized through MomentimRx.

250

This pop hit evolved from a reggae song called “Never Stop”

START ME UP

CSI is like the song in two key ways:  1.) We aim to function with speed & agility, like a start-up.  2.) We are continually evolving our approach to the work.

M
e
n
u